# Bionomous

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bionomous

- Industry: Medical Devices & Equipment
- Headquarters: Fribourg, Switzerland
- Website: www.bionomous.ch
- Total disclosed funding: $4.1M
- Latest round: Series A (Jan 20, 2023)
- Investors on record: 5

## About

Based in Switzerland, Bionomous Sàrl operates in the life sciences sector, specializing in automating the screening and sorting of small biological entities through advanced technology solutions.Bionomous SA, founded in 2019 in Fribourg, Switzerland, focuses on the automation of biological entity handling. The company has engaged in two funding rounds, with the most recent being a Series A round on January 20, 2023, where it raised USD 2.7 mn led by Nivalis Group SA along with participation from other investors. The company was co-founded by Ana Ariza and Frank Bonnet, the latter also serving as CEO.Bionomous specializes in the automation of screening, sorting, and dispensing small biological entities, primarily through its flagship product, the EggSorter. This device, initially aimed at zebrafish embryo sorting, has expanded to include various organisms such as Xenopus oocytes and flower seeds, utilizing advanced micro-engineering and artificial intelligence for improved lab efficiency. Additionally, Bionomous provides LabSwipe, allowing customers to create custom image classification algorithms, addressing variability in manual selection criteria, targeting academic and research institutions in Europe and North America.Bionomous generates revenue through the sale of its EggSorter and LabSwipe products to research institutions and laboratories. The company operates on a direct-to-consumer model, providing clients the option to purchase products outright with ongoing support and customization services. Typically, clients acquire the EggSorter for a fixed fee, which includes setup and training, while LabSwipe may be part of a package or offered via a subscription model based on usage needs, accommodating varying budget sizes for small-scale and larger research facilities.In January 2023, Bionomous SA raised USD 2.7 mn, which will be allocated to boost production capacity and expand international product availability. The company is focusing on entering new markets across Europe and North America with plans to launch updated products that enhance their current automation solutions in the near future.

## Funding rounds

- Series A, Jan 20, 2023, $2.7M — Capital Risque Fribourg, Nivalis Group SA, Cybernetix Ventures
- Seed, Sep 9, 2021, $1.4M — Venture Kick, Swiss ICT Investor Club, Nivalis Group SA

## Investors

- Venture Kick (https://capitalatlas.ai/funds/venture-kick) — Seed
- Swiss ICT Investor Club (https://capitalatlas.ai/funds/swiss-ict-investor-club) — Seed
- Nivalis Group SA (https://capitalatlas.ai/funds/nivalis-group-sa) — Seed, Series A
- Capital Risque Fribourg — Series A
- Cybernetix Ventures (https://capitalatlas.ai/funds/cybernetix-ventures) — Series A